The Federal Trade Commission (FTC) is launching a Healthcare Task Force to better focus its enforcement and advocacy on issues of competition and consumer protection within the industry, it announced ...

CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. Per court ...

The Federal Trade Commission has paused its case against CVS Caremark to review a proposed consent agreement that would resolve all claims against the company. The March 23 joint motion from the FTC ...

Match Group and its subsidiary OkCupid has finally settled a lawsuit with the Federal Trade Commission that dates back to its alleged sharing of user data back in 2014. According to the lawsuit, the ...

An appeals court invalidated the Biden-era Federal Trade Commission’s attempt to punish Intuit for allegedly deceptive ads that pitched TurboTax as free. Under then-Chair Lina Khan, the FTC determined ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

March 24 (Reuters) - CVS Health (CVS.N), opens new tab said on Tuesday it has reached a proposed settlement agreement with the Federal Trade Commission on insulin pricing. Pharmacy benefit managers, ...

Interested in writing for CW? Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.

The Federal Trade Commission is forming a new healthcare task force as regulators double down on combating anticompetitive behavior in the sector. On Friday, Commissioner Andrew Ferguson directed FTC ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

CVS Health has reached a proposed settlement with the Federal Trade Commission in the agency’s sweeping case against major pharmacy benefit managers for allegedly inflating the cost of U.S. insulin.